Company Cellular Biomedicine Group, Inc.
Equities
CBMG
US15117P1021
Biotechnology & Medical Research
Business Summary
Number of employees: 217
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 05/02/13 |
Yi Hong Yao
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/07/15 |
Stephan Grupp
PRN | Corporate Officer/Principal | - | - |
Xia Meng
PRN | Corporate Officer/Principal | - | 25/06/17 |
Cheng Xiang Dai
PRN | Corporate Officer/Principal | - | 10/07/13 |
Li Zhang
PRN | Corporate Officer/Principal | - | - |
Andrew Chan
LAW | General Counsel | 66 | 05/02/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Schafer
BRD | Director/Board Member | 77 | 11/10/19 |
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 05/02/13 |
Chun Kwok Au
BRD | Director/Board Member | 51 | 10/11/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,533,547 | 9,058,540 ( 44.12 %) | 1,055,499 ( 5.140 %) | 44.12 % |
Company contact information
AbelZeta Pharma, Inc.
9605 Medical Center Drive Suite 100
20850, Rockville
+240 552 5870
http://www.cellbiomedgroup.comSector
1st Jan change | Capi. | |
---|---|---|
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+47.02% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |